Ironwood Pharmaceuticals.
company in Cambridge, United States
- Reports this week
- 1
- Active events
- 1
- Connections
- 29
What's happening
Active this week
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Ironwood Pharmaceuticals filed required SEC disclosure regarding insider trading transactions.Some support1 report
-
Ironwood Pharmaceuticals and Guardian Pharmacy Services, Inc. are medical companies whose stock price volatility is being monitored against the S&P 500 market index.Some support4 reports
-
Ironwood Pharmaceuticals was classified in the Zacks Medical - Drugs industry in August 2025.Some support1 report
-
Ironwood Pharmaceuticals plans to align with the FDA regarding the design of its clinical trials.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Ironwood Pharmaceuticals this week
News at the entities that move Ironwood Pharmaceuticals most-
SEC StructuralGlobus Maritime Limited, which trades on Nasdaq, disclosed an acquisition and a director's share purchase via an SEC filing.Moves Ironwood Pharmaceuticals
-
FDA StructuralThe FDA's authorization decision sparked criticism from the American Lung Association, which was also involved in a public statement via Thomas Carr.Moves Ironwood Pharmaceuticals
-
Jefferies Financial Group Mentioned togetherAcrivon Therapeutics, focusing on RAS-driven cancers, is listing shares on Nasdaq, with Jefferies providing investment research.Moves Ironwood Pharmaceuticals
-
Nasdaq StructuralMakeMyTrip filed its IPO application with Nasdaq on July 17, 2026.Moves Ironwood Pharmaceuticals
-
MarketBeat Mentioned togetherRoyal Bank of Canada and Raymond James Financial updated their ratings and target price for CareTrust REIT.Moves Ironwood Pharmaceuticals
-
AbbVie Mentioned togetherAbbVie announced a joint development partnership with IGI, led by Lida Pacaud.Moves Ironwood Pharmaceuticals
Connections
The 7 strongest of 29, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
FDA mandates specific clinical trial requirements and design alignment for Ironwood Pharmaceuticals' drug development.
-
SEC Structural
Ironwood Pharmaceuticals is subject to SEC regulations requiring disclosure of insider trading transactions.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group provided analyst rating upgrades and raised shares of Ironwood Pharmaceuticals.
-
Nasdaq Structural
Ironwood Pharmaceuticals is listed on the Nasdaq electronic stock exchange.
-
MarketBeat Mentioned together
MarketBeat reports financial consensus target prices for Ironwood Pharmaceuticals.
-
AbbVie Mentioned together
No direct coupling or interaction between AbbVie and Ironwood Pharmaceuticals was observed in the provided evidence.
-
AstraZeneca Mentioned together
No direct relationship between Ironwood Pharmaceuticals and AstraZeneca was observed in the provided evidence.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
2 eventsJuly 2026
1 eventShow 1 earlier month
June 2026
3 events- Ironwood Pharmaceuticals and Guardian Pharmacy Services, Inc. are medical companies whose stock price volatility is being monitored against the S&P 500 market index.
- Ironwood Pharmaceuticals was classified in the Zacks Medical - Drugs industry in August 2025.
- Ironwood Pharmaceuticals plans to align with the FDA regarding the design of its clinical trials.